NPI: 1003889171 · TUSCALOOSA, AL 35401 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,439 | $518K |
| 2019 | 23,881 | $475K |
| 2020 | 19,983 | $423K |
| 2021 | 15,632 | $269K |
| 2022 | 15,256 | $187K |
| 2023 | 6,251 | $155K |
| 2024 | 2,360 | $85K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 35,336 | 2,500 | $1.42M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 37,326 | 1,929 | $597K |
| J1756 | Injection, iron sucrose, 1 mg | 7,769 | 1,664 | $38K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 530 | 193 | $26K |
| 83970 | 1,309 | 982 | $14K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,842 | 1,237 | $6K |
| 82108 | 549 | 415 | $3K | |
| A4657 | Syringe, with or without needle, each | 2,053 | 1,658 | $3K |
| 83550 | 659 | 502 | $1K | |
| 82728 | 709 | 542 | $1K | |
| 85045 | 1,255 | 1,010 | $1K | |
| 85041 | 1,475 | 1,191 | $1K | |
| 83540 | 762 | 570 | $1K | |
| 85048 | 1,472 | 1,190 | $1K | |
| 82607 | 62 | 57 | $150.72 | |
| 82746 | 47 | 42 | $72.30 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 633 | 307 | $0.00 |
| 90674 | 14 | 13 | $0.00 |